Elisa Uliassi
Affiliations: | Pharmacy and Biotechnology | University of Bologna |
Google:
"Elisa Uliassi"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Kenneth A. Jacobson | research assistant | 2014-2015 | University of Bologna |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Exertier C, Salerno A, Antonelli L, et al. (2024) Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis. Journal of Medicinal Chemistry. 67: 402-419 |
| Albertini C, Salerno A, Atzeni S, et al. (2022) Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis. Acs Chemical Neuroscience |
| Gorecki L, Uliassi E, Bartolini M, et al. (2021) Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease. Acs Chemical Neuroscience. 12: 1698-1715 |
| Perone R, Albertini C, Uliassi E, et al. (2021) Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy. Chemmedchem. 16: 187-198 |
| Bruno S, Uliassi E, Zaffagnini M, et al. (2017) Molecular basis for covalent inhibition of glyceraldehyde-3-phosphate dehydrogenase by a 2-phenoxy-1,4-naphthoquinone small molecule. Chemical Biology & Drug Design |
| Junker A, Balasubramanian R, Ciancetta A, et al. (2016) Structure-Based Design of 3-(4-Aryl-1H-1,2,3-triazol-1-yl)-Biphenyl Derivatives as P2Y14 Receptor Antagonists. Journal of Medicinal Chemistry |
| Kiselev E, Balasubramanian R, Uliassi E, et al. (2015) Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y14 receptor. Bioorganic & Medicinal Chemistry Letters. 25: 4733-9 |